HCA HEALTHCARE ($HCA) is expected to release its quarterly earnings data on Friday, April 25th before market open, per Finnhub. Analysts are expecting revenue of $18,439,287,795 and earnings of $5.82 per share.
You can see Quiver Quantitative's $HCA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HCA HEALTHCARE Insider Trading Activity
HCA HEALTHCARE insiders have traded $HCA stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HCA stock by insiders over the last 6 months:
- JENNIFER BERRES (SVP & Chief Human Res. Officer) has made 0 purchases and 2 sales selling 9,533 shares for an estimated $3,075,240.
- PHILLIP G BILLINGTON (SVP-Internal Audit Services) sold 3,897 shares for an estimated $1,363,950
- EROL R AKDAMAR (Group President) sold 2,900 shares for an estimated $1,023,700
- KATHLEEN M WHALEN (SVP & Chief Ethics Officer) sold 1,474 shares for an estimated $527,677
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HCA HEALTHCARE Hedge Fund Activity
We have seen 504 institutional investors add shares of HCA HEALTHCARE stock to their portfolio, and 602 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,468,086 shares (-46.7%) from their portfolio in Q4 2024, for an estimated $440,646,012
- BANK OF AMERICA CORP /DE/ removed 1,195,146 shares (-34.8%) from their portfolio in Q4 2024, for an estimated $358,723,071
- BLACKROCK, INC. removed 1,086,915 shares (-7.0%) from their portfolio in Q4 2024, for an estimated $326,237,537
- QUBE RESEARCH & TECHNOLOGIES LTD added 950,697 shares (+1140.7%) to their portfolio in Q4 2024, for an estimated $285,351,704
- WELLINGTON MANAGEMENT GROUP LLP removed 591,060 shares (-8.4%) from their portfolio in Q4 2024, for an estimated $177,406,659
- ROYAL LONDON ASSET MANAGEMENT LTD added 574,239 shares (+62.0%) to their portfolio in Q4 2024, for an estimated $172,357,835
- JPMORGAN CHASE & CO added 544,333 shares (+22.9%) to their portfolio in Q4 2024, for an estimated $163,381,549
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HCA HEALTHCARE Congressional Stock Trading
Members of Congress have traded $HCA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HCA HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $HCA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- KeyBanc issued a "Overweight" rating on 01/07/2025
- Oppenheimer issued a "Outperform" rating on 10/28/2024
To track analyst ratings and price targets for HCA HEALTHCARE, check out Quiver Quantitative's $HCA forecast page.
HCA HEALTHCARE Price Targets
Multiple analysts have issued price targets for $HCA recently. We have seen 3 analysts offer price targets for $HCA in the last 6 months, with a median target of $400.0.
Here are some recent targets:
- Matthew Gillmor from KeyBanc set a target price of $370.0 on 01/07/2025
- Michael Wiederhorn from Oppenheimer set a target price of $400.0 on 10/28/2024
- Ann Hynes from Mizuho Securities set a target price of $425.0 on 10/28/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
